Patent · US Active

FBPase inhibitors for diabetes

US7868030B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Marcel Gubler · Arlesheim, CH
Wolfgang Haap · Bad Kötzting, DE
Paul Hebeisen · Basel, CH
Eric A. Kitas · Aesch, CH
Bernd Kuhn · Sursee, CH
Rudolf E. Minder · Ettingen, CH
Brigitte Schott · Chicago, US
Hans Peter Wessel · Heitersheim, DE

Key dates

Filing date	May 30, 2007
Grant date	Jan 11, 2011
Priority date	—
Expiry date	Jan 13, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formulaas well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.